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Abstract: The transition towards a biobased economy requires innovations. In addition to the usual 
challenges of innovation trajectories, the characteristics of biobased innovations cause extra difficulties. 
To lower the failure rate of innovation trajectories in general, companies tend to form R&D collaborations. 
Choices made during the formation of such R&D collaborations play a key role in the project’s success. 
Here, one may benefit from the social sciences. This paper presents a perspective on what the social 
sciences may bring to analyze and improve the formation process of biobased R&D collaborations. The 
paper also provides an overview of relevant innovation and transition models, and lists the dominant 
variables in such formation processes (biobased characteristics and general determinants), and the 
guidelines that seem useful. Although each model has its advantages, none of the innovation and transition 
models studied addresses both the phases of a formation process of a biobased R&D collaboration and 
the variables involved in each phase. Concerning the formation process of biobased R&D collaborations, 
the literature addresses social, organizational, technological, economic, and environmental variables. The 
key determinants of multi-partner R&D collaborations are partner properties, motives to join a consortium, 
appropriability of a firm, and project properties. The descriptions of their influence on an R&D collaboration 
presented here can be used as guidelines, as recommendations, in processes for the formation of relatively 
less complex R&D collaborations. The influence of biobased characteristics – such as type of innovation 
(drop-ins versus novel materials), biorefinery, biomass supply and technological challenges – on R&D 
collaboration have not been studied systematically as yet. © 2020 The Authors. Biofuels, Bioproducts, 
and Biorefining published by Society of Chemical Industry and John Wiley & Sons, Ltd
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Introduction
T
he biobased economy is defined as an economy 
where biomass is used to produce not only food and 
feed but also energy, materials, and chemicals.1 For 
the transition towards such an economy, technological 
innovations are necessary, and diverse stakeholders – 
especially government, research, and industry – have to join 
forces to develop the necessary technologies, products, and 
processes.2,3 The European Commission alone has already 
invested over 5.5 billion euro in over a thousand biobased 
innovation projects, for the period 2015–2020.
Innovation projects in general show low success rates, and 
biobased innovations seem to perform no better. Concerning 
product development, in general, the literature indicates a 
wide range of failure rates (30%–80%).4 In addition to the 
common difficulties in innovation trajectories, biobased 
innovations are part of the wider transition from a well-
established and efficient fossil-based economy to a biobased 
economy. This transition requires complex, interdependent 
development of technologies, value chains, and societies.5 The 
first hurdle already is the fact that there are problems with the 
availability of biobased resources that fulfill certain criteria 
at reference prices, and which could serve as feedstocks 
for biobased processes. Many biobased innovations focus 
on applying side streams, avoiding the use of food crops. 
For these kinds of feedstocks, in particular, availability and 
mobilization can pose serious problems. One may think of 
side streams that offer good potential as biobased resources, 
but they are spatially scattered (such as palm kernel wastes, 
coffee residues, or pellets of new lignocellulose sources such 
as reed or miscanthus) and are difficult to certify, for instance 
in terms of quality or sustainability.6,7
The challenges to biobased innovations are multiplied when 
pondering collaborations on innovations by two distinct 
industries; we refer to the chemical sector and the agro-food 
sector, each with its unique industrial, if not sectoral, culture, 
fully optimized production scales, and routinized business 
practices. For example, a conventional chemical company 
that intends to change from fossils to biobased raw materials 
is a novice when it comes to contracting, transporting, 
processing, and storing non-homogeneous biomass-based 
raw materials. A collaboration between such a chemical 
company and an agro-food company could then be a way 
forward, notwithstanding the challenges such a cooperation 
poses. As already pointed out in the corporate strategy-
classic by Ansoff,8 for innovations with more than one major 
uncertainty (in the case of biobased innovations, novel market, 
new products, new raw materials, new technology, etc.) a 
way of reducing uncertainties is a collaboration with the right 
partners. A study on bioplastics9 recognizes these complexities 
and recommends addressing not only technological and 
economic variables in biobased innovation projects, but 
also social variables (e.g. societal benefits of bioplastics, the 
stakeholders of the value chain, public communication), and 
environmental variables (e.g. environmental impact, Life Cycle 
Analysis (LCAs), accountability systems).
To lower the failure rate of complex innovation projects, 
companies tend to form research and development 
(R&D) collaborations.10,11 These interorganizational R&D 
collaborations – more specifically R&D consortia – are 
defined as relationships between three or more R&D partners 
to pursue both individual and shared goals.11 Regular 
subcontracting is thus not core to our study. Prime motives 
for joining a specific R&D consortium are cost sharing, risk 
sharing, and skill sharing.12,13 The success rate of joint R&D 
projects depends on the motives of the partners to join, 
and the type of partners.10,14,15 Even during the formation 
process of R&D projects, therefore, the partners have to make 
important decisions such as partner choice (consortium 
composition), goal of collaboration, and contract conditions, 
which will play a key role in the project’s success. Sometimes 
the formation process of an R&D collaboration and the 
corresponding decisions are orchestrated by a triggering 
entity, a so-called orchestrator or innovation broker.16-18 
In practice, the role of such an orchestrator is directed at 
lowering the failure rate of the formation process of complex 
R&D collaborations.
The authors of this paper, working for applied research 
institutes and universities, have decades of experience as 
researchers and business developers (orchestrators) with 
biobased R&D projects and their formation processes. To 
lower the failure rate of these projects we arrived at models 
and guidelines from the social sciences to improve the 
process of forming R&D projects. The aim of this paper is 
to show the core of what the social sciences have to offer to 
analyze and improve the formation process of a biobased 
R&D collaboration. With this paper we provide support to 
researchers and orchestrators by giving an overview of useful 
models, critical variables and guidelines, and a perspective 
on their usefulness during the formation process. In this way 
we come up with an action perspective for those setting up 
biobased R&D consortia. The usefulness of several models 
and guidelines will be illustrated with cases, indicated in 
italics.
The formation process for an R&D collaboration generally 
consists of several phases, from idea generation, partner 
search / selection, proposal and consortium development, 
to signing the contract. Our study focuses on the phases 
between idea generation and signing the contract.
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We conducted a review study to investigate whether the 
literature provides useful models, lists of critical variables, 
and guidelines that improve the formation of biobased 
R&D collaborations. The literature contains a vast number 
of studies on R&D collaboration in general, but offers 
surprisingly little systematic information on their formation 
process. The first step of the review study was a literature 
search using the academic journals / databases Scopus 
and Web of Science, using combinations of the following 
keywords: consortium, formation, innovation, R&D, model, 
network, multi-partner alliances, and biobased. Second, the 
long resulting list of publications was screened; publications 
strictly reporting technological innovations, or social 
aspects of an innovation after the formation process, were 
excluded. Third, trimming the still large amount of shortlisted 
papers and topics led to the exclusion of studies regarding 
intellectual property rights, public policies, and contracts. The 
fourth and final step was a forward and backward reference 
search to arrive at the most relevant publications.
The literature search resulted in over a hundred relevant 
publications, which were divided by the topic addressed, such 
as the characteristics of a biobased collaboration, transition 
and innovation models, and determinants of collaboration. 
The models are subdivided into transition models, describing 
the context of the innovation, and innovation models, 
describing the innovation process. Following the bioplastics 
innovation-study by Iles and Martin9 we also look into 
relevant variables of the formation process of a biobased R&D 
collaboration, divided in biobased characteristics and general 
determinants. Finally, based on the way these variables affect 
the success rate of a project we form a list of guidelines, being 
recommendations not rules, for partners / brokers useful for 
improving the process of formation of R&D collaborations.
The remainder of the paper is organized as follows 
(Fig. 1). The next section presents a short description of the 
biobased characteristics. An overview is then given of the 
core of relevant transition and innovation models available 
in the literature. The paper then focuses on the general 
determinants influencing R&D collaborations, between 
two partners and in multi-partner consortia, respectively. 
Consideration is then given to the way in which variables 
affect project success, and to guidelines for partners / brokers, 
which are recommendations rather than rules, useful for 
the orchestration of the process of formation of an R&D 
collaboration. The concluding section summarizes the 
findings, and proposes areas for future research.
Biobased characteristics
The increasing scarcity and insecurity of fossil resources 
and the problems of fossil-related climate change have led 
to a search for alternative resources, which has intensified in 
recent decades.5 If we only take technological feasibility into 
account, all chemicals and materials based on fossil resources 
can be substituted by biobased resources.19 But such biobased 
innovations require collaborations. In this section, we 
describe the characteristics of a biobased R&D collaboration: 
biomass supply, bio-refinery, technological challenges, type of 
Figure 1. Knowledge to improve the process of forming biobased R&D collaborations.
908 © 2020 The Authors. Biofuels, Bioproducts and Biorefining published by Society of Chemical Industry and John Wiley & Sons, Ltd.  
|  Biofuels, Bioprod. Bioref. 14:905–923 (2020); DOI: 10.1002/bbb.2123
BTPM Israël-Hoevelaken et al. Perspective: Formation of biobased R&D collaborations
innovation, new chains / collaborations, and society-sensitive 
issues.
Biomass supply
Evidently, an important factor for the success of a biobased 
innovation is the availability of biomass with the right 
specifications and price.20
Bio-refinery
The fractions of raw materials and corresponding applications 
of the products of a bio-refinery are more diverse than an 
oil refinery; biobased raw materials consist of a broader 
range of chemical compounds, and they are applicable to an 
even wider variety of markets (e.g. food, feed, materials, and 
chemicals). As a consequence, choosing the combination of 
the most suitable applications, sources, and corresponding 
bio-refinery processing steps is more complex than for a 
petrochemical refinery. In an ideal situation, the biomass is 
fully used, leaving no residues, in applications obtaining the 
highest aggregate value.1
Technological challenges
The biobased economy has to address three technological 
challenges:21
1. Breakthrough technologies: It is a research-intensive 
field, where fundamentally new knowledge and 
capabilities have to be created and acquired.
2. Cross-sectoral collaboration: Interdisciplinary 
approaches are required because it has a cross-sectoral 
character, drawing upon a variety of sciences and 
technologies.
3. Acceptance rate: Acceptance of its new products and 
technologies may become difficult, because of higher 
risk perceptions among users.
Type of innovation
Biobased innovations can be divided into two groups, namely 
drop-ins and novel materials.1 First, drop-in innovations are 
based on the substitution of the fossil-based building blocks 
in products and processes by (essentially) identical biobased 
building blocks. A case example is the substitution of fossil-
based ethene by the biobased alternative, ethene from sugar 
cane, in the production process of poly-ethene by the Brazilian 
company Braskem.22 Drop-in innovations are, in general, 
incremental innovations, because no changes or only small 
changes of the formulation are necessary, the end product 
is in general exactly the same as the product it replaces, and 
it can be used in the same applications, so no additional 
product development is needed. However, the production 
and sourcing of the identical biobased building block will 
require new raw materials and new production processes, 
and can therefore extend beyond an incremental innovation. 
A major challenge for the substitution of inputs by biobased 
feedstocks is the size of the already existing market and the 
cost of production of the drop-in in a novel biobased process, 
which still needs industrial optimization in comparison with 
an already established fossil-based industrial process. This is 
certainly the case if one has to compete with larger players 
benefitting from economies of scale in their processes and / 
or markets, and in their lobbying to governments.
Biobased innovations related to novel materials, the second 
group of innovations, exploit the broad range of chemical 
functionalities for the development of new building blocks, 
from which new materials may be developed, generally with 
new technical functionalities. Compared to fossil-based 
raw materials (petrochemical hydrocarbons), biobased raw 
materials consist of a broad range of chemical compounds 
(e.g. carbohydrates, proteins, and fats) and an even broader 
range of chemical functionalities, properties. Such an 
innovation is called a radical innovation. A case example 
is biobased packaging material based on polylactic acid 
(PLA). The production of PLA required the development of 
new production processes and a new production plant: PLA 
is not only a biobased alternative for fossil-based packaging 
material but it also gives an added value to the functionality 
of the product. The added value in this case is that PLA and its 
monomers are non-toxic, in some applications replacing a toxic 
monomer of polystyrene, while in certain applications PLA also 
has the advantage that it is biodegradable. Other examples 
of added value may be lower carbon dioxide emissions 
during production or in use, less harmful for human health, 
and better technical functionalities (e.g. biodegradability, 
solubility, barrier properties, strength, UV resistance).
New chains / collaborations
In some cases the whole supply chain must be developed, 
from biomass production, biorefinery, production of 
materials, product development, up to market introduction. 
In that case new market players and major investments may 
be necessary.23 For biobased applications the agro-food 
and forestry sectors are the main sources of biobased raw 
materials. Companies (e.g., chemical and energy companies) 
that switch from fossil to biobased raw materials have to build 
relationships with biobased raw-material suppliers, typically 
unfamiliar to them.9 Furthermore, these switching companies 
are used to storing, transporting, and handling fossil-based 
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resources, but they are not used to the diverse biobased 
resources that often need to be sourced from many small 
production locations.9 The transition towards a biobased 
economy is often expected to require radical innovations and 
new supply chains linking, at best, remotely related sectors.24
Society-sensitive issues
The transition to a biobased economy is a complicated 
trajectory, touching upon societally sensitive issues, such 
as the use of genetic modification and the food versus fuel 
discussion.25
Depending on their characteristics, specific biobased R&D 
collaborations can differ in complexity. A collaboration 
with a large number of partners will be less complex when 
these companies just want to share risks in exploring a new 
technology. It will be evident that an R&D collaboration 
with three partners, developing an incremental, drop-in 
innovation, based on mature technology, is less complex 
than a collaboration, which we have experienced, with more 
than 10 partners coming from different industries and with 
different interests, developing both radical and incremental 
innovations, based on immature technologies.
Transition and innovation models
This section gives an overview of the core of the relevant 
transition and innovation models that may relate to the 
process of forming biobased R&D consortia. The first 
subsection addresses transition models, typically used to 
analyze and to facilitate major transformations in societal 
functions towards, in our case, the biobased economy. The 
second subsection considers innovation models. The initial 
presentation of general innovation models is extended by the 
presentation of models specifically suited for the process of 
forming an R&D collaboration.
Transition models
A transition model describes major transformations in 
societal functions, such as transportation, communication, 
housing, and feeding.26 Examples of such transitions are the 
transformation from sailing ships to steamships, and from 
an oil-based economy to a biobased economy. A transition 
involves technological innovations, but also innovations 
in user practices, regulations, industrial networks, 
infrastructures, and symbolic meaning or culture. We arrived 
at, and will describe, two transition models useful for the 
analysis of the processes necessary for the transition to a 
biobased economy: strategic niche management (SNM) 
with a multi-level perspective (MLP), and technological 
innovation systems (TIS).
Strategic niche management
Strategic niche management (hereafter SNM) claims that an 
innovation can be facilitated by creating technological niches. 
A niche is a protected space that allows experimentation with 
the co-evolution of technology, user practices, and regulatory 
structures. The assumption is that, if such niches are 
constructed appropriately, they can act as building blocks for 
broader societal changes towards sustainable development.27
In the set of articles developing SNM, one article added 
and elaborated a multilevel perspective to SNM (Fig. 2),26 
distinguishing the following three levels: the sociotechnical 
landscape level, regime level, and the level of the niches. The 
landscape level is formed by the material and immaterial 
context of societies.28 In other words the landscape level is the 
macro context, and items at this level are natural resources 
(e.g. fossil fuel, biomass), climate (international), political 
practices, and social cultures. Climate change and related 
agreements are objectives at the landscape level. The regime 
level can be defined as the grammar or rule set, embedded 
in a complex of engineering practices, production process 
technologies, product characteristics, skills and procedures 
– the ways of handling.28 For the biobased economy, the 
literature recognizes several regimes – typically the chemistry 
regime, the agricultural regime, and the energy regime.5 
The objects at the third and most specific level are niches. A 
Figure 2. Multilevel perspective model.26 Innovative 
developments, represented by the small circles at the niche 
level, may cluster and lead to changes at the regime level. 
Many changes at the regime level may lead to changes at 
the landscape level and thus to a transition.
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biobased innovation can be labeled as a niche. To become 
a successful innovation and to evolve from niche level to 
maturity at regime level, a niche must execute three processes: 
Voicing and shaping of expectations, building social 
networks, and the learning process.29 A case example of an 
analysis of these three processes in a biobased application is the 
study of biofuels by van der Laak et al.30
Applying the multilevel perspective to a technological 
innovation, technological change occurs by linkages between 
levels, and changes at the levels.29 Changes at the landscape 
level – for instance a sharp rise or fall in oil prices – can put 
pressure on the energy regime or the chemistry regime, 
and may result in changes at the level of these regimes. For 
instance, under rising oil prices chemical companies that do not 
possess naphtha crackers for the production of their feedstock 
from oil may be willing to look for feedstock diversification, 
and thus consider biomass as a raw material. Next, less stable 
regimes may create market momentum for new technologies, 
like biochemicals developed earlier in niches.
Strategic niche management in a multilevel perspective 
can be useful during the process of the formation of an R&D 
collaboration. For example, information about stakeholders 
in the chemical industry, at the regime level, can be useful 
for an R&D consortium partner search at niche level. 
However, as SNM cannot be used to give an analysis of the 
status of an innovation and possible shortcomings, such as 
the consortium composition, one has to resort to another 
transition model: Technological innovation systems (TIS).
Technological innovation systems
A TIS is based on the innovation system concept introduced 
by Dosi et al.31 and Lundvall32 in the 1980s. According to 
a TIS, an innovation is not determined merely by variables 
within one company but it is simultaneously part of a larger 
innovation system, which includes the market, government, 
and research institutes. A TIS is a type of innovation system 
that can be used to analyze and evaluate the development of 
a particular technological field.33 A TIS can give an overview 
of the functioning of an innovation system, and its failure at 
a certain time. The TIS-analysis can be conducted by using 
the following set of seven functions: entrepreneurial activities, 
knowledge development, knowledge exchange, guidance of 
the search (selecting between various technological options 
that could be developed), formation of markets, mobilization 
of resources, and counteracting resistance to change.34 These 
functions address technological, economic, and social variables 
of an innovation system. The TIS analysis shows per function if 
the development of the function is sufficient or if an adjustment 
is necessary. The TIS was used to analyze and evaluate several 
renewable energy cases (hydrogen, biofuels, natural gas).35,36 The 
conclusion was that realizing a virtuous cycle in an innovation 
system requires functions to reinforce each other over time. The 
Netherlands’ biofuels innovation system was considered to be 
driven by the function’s entrepreneurial activities, support from 
advocacy coalitions, and resource mobilization.36
We can conclude that transition models can give a broad 
perspective on an innovation. This can be used during the 
process of forming an R&D consortium. A TIS analysis 
complements the SNM analysis by providing the status of an 
innovation system at a certain moment in time. A TIS can, for 
example, be used to analyze the status at a certain moment in 
time of a biobased R&D consortium in formation, and it may, 
for example, indicate missing stakeholders in this consortium.
Having presented, in brief, the essentials of the broader 
transition models, the SNM and the TIS, which may provide 
the wider overview of the relevant variables that impact 
innovations and R&D collaborations, we now turn to the 
more specific innovation models, to study the formation 
processes of an R&D collaboration.
Innovation models
This subsection presents core lessons from the established 
innovation management literature, namely the linear 
innovation model and the circular innovation model, 
complemented by specific models for the process of the 
formation of an R&D collaboration. An innovation can be 
defined as the invention, development, and implementation 
of new ideas into products and processes.37 A vast amount 
of research has been done on the development of innovation 
models, in general providing variations on a simplified figure 
or flow-chart representation of an innovation process.38 These 
models can be useful for the formation process of an R&D 
consortium because they give insights into the sequence 
of steps an innovation goes through. We will discuss the 
different types of models most relevant for this paper, going 
from the simple linear models to more complex models, 
ending with circular models.38
One of the first, but still informative, innovation models 
is the linear innovation model,39 which presents a sequence 
or chain of key steps, from basic research, applied research, 
via development to diffusion, necessary for an innovation. 
An offspring of it is the method of estimating the maturity of 
technologies on the basis of nine technology readiness levels 
(TRLs), developed by NASA in the 1970s, and in use by, for 
example, the EU. Over time, different versions of this linear 
model were developed and used (see Godin)39 such as the 
innovation funnel to prioritize ideas repeatedly, and resource 
allocation to R&D projects.40
Although these linear innovation models are still in 
use because of their simple, convenient representation of 
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the sequence of activities, they have also been criticized. 
First, not all activities in the model are always needed for 
an innovation. Second, in the early 1970s the innovation 
process within a firm became more integrated with other 
functions of the firm; for example R&D became linked with 
marketing.41 As a result more integrated innovation models 
were developed for the innovation process (essentially) within 
a single firm.42,43
Since the turn of the century circular innovation models have 
begun to appear.38,44,45 These models explicitly reflect that 
an innovation process is a perpetual process, along a path of 
activities that has no fixed starting or ending point, stretching 
out beyond the boundaries of a single firm. For example, 
the cyclic innovation model (CIM)44 is a circular innovation 
model that can be applied to an innovation with two or more 
partners (see Fig. 3). The model replaces the linear and the 
integrated models by a circle with four areas of activities 
similar to the steps in a linear model, namely scientific 
exploration, technological research, product development, and 
market transition, but is connected by four related cycles. The 
interaction between scientific exploration and technological 
research is depicted by the technically oriented science cycle. 
The development of new technologies takes place in this 
cycle, using both scientific and technological knowledge. 
Recall, for example, the development of the genome editing 
technology CRISPR/Cas, which allows permanent modification 
of genes within organisms. The integrated engineering cycle 
represents the interaction between technological research 
and product development. New product development takes 
place in this cycle, using both technological knowledge and 
product requirements. The optimization of the biotechnological 
production process of a novel biochemical by using strain 
modification technologies such as CRISP / Cas is an example of 
such new product development.
The interaction between product development and market 
introduction is depicted by the differentiated service cycle. 
In this cycle, innovation takes place based on information 
obtained from customers and the service sector. An example 
is the development of a small-scale fermenter, based on criteria 
set by farmers, who want to use agricultural rest streams as 
raw material for biotechnological methane production and 
energy. Finally, the interaction between market transitions 
and scientific research is depicted by the socially oriented 
science cycle. In this cycle, the systematic development of new 
insights into socioeconomic trends and market transitions 
takes place. An example is the development of a model 
addressing the socio-economic aspects of a biotechnological 
innovation.Figure 3, as a whole, sets the innovation arena for 
the relevant activities, processes, and related stakeholders 
(that is, manufacturing and processing industry, public and 
private service sector, soft knowledge infrastructure and hard 
knowledge infrastructure).
Circular models provide insights concerning the type 
and sequence of the determinants and activities of an 
Figure 3. Cyclic innovation model (CIM).44
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innovation. However, even the circular innovation model 
does not address the process of formation of an innovation 
consortium, the main reason being that most of the models 
are still focused on improving intrafirm, not interfirm, 
innovation processes.
In sum, the linear and circular innovation models presented 
provide useful insights into the type and sequence of the 
determinants and activities of an innovation, but we still need 
more dedicated literature to address the formation process of 
an R&D collaboration.
Models for the formation process of an R&D 
collaboration
This sub-subsection provides an overview of the innovation 
models that target the formation process of an R&D 
collaboration. Interestingly, the literature review resulted 
only in the model by Ring and Van de Ven46 (see Fig. 4), 
which had been developed on the process of forming inter-
organizational relationships in general.
This closed-cycle model consists of an ongoing sequence of 
three phases in the formation process, namely negotiation, 
commitment, and execution. Doz and Baburoglu47 elaborated 
on this more general model to arrive at the following 
nine activities, which they call preconditions, for an R&D 
collaboration:
1. Identifying interdependencies.
2. Developing shared norms of problem solving.
3. Triggering cooperation: The need for a focal entity.
4. Selecting participants.
5. Making the shadow of the future visible.
6. Securing the participants sustained ability to contribute.
7. Designing cooperation.
8. Learning and adjusting over time.
9. Expansion of scope and deepening of commitments.
An R&D collaboration can vary in consortium structure 
and in contract explicitness.47 The multi-partner R&D 
collaboration could be based on explicit commitments 
and contracts or it could be founded on less formal, 
common ground. Next, at the start of the collaboration, 
the partners can either be asked to join a well-specified 
structure, or the structuring process will emerge over 
time from their interactions. Figure 5 summarizes the 
four different resulting types of collaboration, using 
the dimensions forms of collaboration and enablers of 
collaboration.47
Figure 4. Formation process of an inter-organizational relationship.46
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Although Fig. 5 has no ‘one best pathway’, a collaboration 
seems likely to evolve through several phases as depicted by 
the arrows.18 At the start of a collaboration there is often a 
tentative definition of common ground and relatively little 
structure (process). This can then evolve into more explicit 
contracts with a structural design.47 The numbers in Fig. 5 refer 
to the nine activities mentioned above. The first three activities 
are initial conditions, and the other six are activities related 
to network emergence.18 As far as we are aware, the model in 
Fig. 5 is the only model describing the activities and structuring 
of a formation process of an R&D collaboration. Unfortunately, 
this model does not address relevant variables (e.g. economic, 
social, and technological) per phase of the formation process.
In addition to this model with nine steps,47 scholars describe 
the phases generally necessary for the process of forming a 
collaboration between the focal firm and a partner:48,49
1. Defining the firm’s goals.
2. Selecting the partner.
3. Establishing the collaboration agreement / contract.
4. Implementing the partnership.
Other scholars address the formation process when 
describing the phases of the life cycle of an R&D collaboration 
between two partners:50,51
1. Initiation phase.




Interestingly, there seems to be no similar, recognized 
literature addressing the variables per phase for the formation 
process of a multi-partner R&D collaboration (consortium).
It is justifiable to conclude that there are some models in 
the literature for the process of forming a multi-partner R&D 
consortium, addressing the activities, phases, and structuring 
of a formation process. However, they do not address the 
relevant variables (e.g. economic, social, and technological) 
per phase of the innovation process. More generally, we 
conclude that, so far, no innovation model seems to exist 
addressing both the phases of an innovation process and the 
relevant variables for each phase.
Returning to our objective of finding models for the process 
of forming biobased (multi-partner) R&D collaborations, so 
far we have reviewed both transition and innovation models. 
Although each model has its advantages, we have to dig 
deeper to find models that may inform us regarding both the 
formation process phases of a biobased R&D collaboration 
and the variables involved.
R&D collaboration between two 
partners
Scholars have extensively studied the performance of 
R&D collaborations between two partners, often using 
the technological alliance framework.52-54 A technological 
alliance is a cooperative agreement between two partners 
(e.g. R&D cooperation) for achieving a durable technological 
competitive advantage.55 In this section and the next we 
describe the key determinants of an R&D collaboration 
between two (respectively multiple) partners, based on the 
literature on alliances.
The key determinants of an R&D collaboration can be 
divided into three groups: partner properties, motives, 
and appropriability.56 The appropriability of a firm is the 
ability of that firm to apply the knowledge obtained from 
an R&D collaboration in such a way that it profits from 
the knowledge. Table 1 provides short descriptions of the 
determinants of an R&D collaboration, and their influences 
on an R&D collaboration.
The prime motives for firms to join an R&D collaboration 
are resource sharing, cost sharing, risk sharing, shortening 
the innovation process, and entry to foreign markets.55,57,58 
These prime motives can be summarized in a resource-based 
view: A firm wants to access necessary resources it does not 
already possess.57,59 The potential of a collaboration between 
two partners will be positively influenced by the level of 
complementarity of the resources that are brought into the 
collaboration by the partners.59 The resources can be divided 
into four groups: financial (e.g. cost sharing), technological 
(e.g. knowhow and R&D), physical (e.g. materials and 
facilities), and managerial resources (e.g. internationalization 
skills). The risks can be divided into relational risk (e.g. trust 
Figure 5. Formation process model by Doz and 
Baburoglu.47
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Table 1. Determinants for the formation process of a collaboration between two partners and their 
influences.
Determinant Description Description of the influence
Partner firm properties
Size The number of employees within the partner firm A positive impact on a collaboration,56,67,68 except for 
Doz and Baburoglu.47
Collaboration between a 
large and a small firm
• Divergence of mutual purpose in time
• Consistency of the position of the R&D 
collaboration within the large firm
• Interface between top management and middle 
management in large firm
• Negative impact on collaboration
• Positive impact on collaboration 
• Good interface has a positive impact on 
collaboration62
R&D intensity The annual R&D investments divided by the sales 
in that year
Positive impact on the propensity of a firm to form R&D 
collaborations.47,63
Prior experience The amount of experience of a firm with R&D 
collaborations
Positive impact on the propensity of a firm to form R&D 
collaborations.45,48,64
Type of partner Relation of two partners: Two competitors, supplier 
and customer, or public research organization 
(PRO) and firm
A collaboration between competitors or between public 
research organization and a firm is more likely to fail or 
to be delayed than a collaboration between supplier and 
customer.61
Type of industry: For example chemical, food, 
energy
A radical innovation has more chance to succeed if the 
partners come from a different kind of industry.49,50,64
Geographic position The geographic distance between the two partners The more distant a partner, the less likely a firm will start 
a collaboration. For an incremental innovation a diversity 
of the geographic position of the partners is a benefit.47,64
Motives
Motives The motive (resource sharing, cost sharing, risk 
sharing, shortening innovation process, and 
entry to foreign markets) influences the R&D 
collaboration.
Based on the resources necessary and the risks 
taken, a framework was developed to understand the 
prime considerations in forming an R&D collaboration 
(Table 2).51,52
Appropriability of both firms
Spillovers The knowledge obtained from the partner during 
the project
The more a firm expects positive spillovers the more likely 
it will join a collaboration.56,65
Lead time The time necessary to get from an idea to a new 
product
The shorter the lead time the better. Lead time is a major 
determinant for a collaboration between a customer and 
a supplier.56
Tacit knowledge Knowledge that is difficult to transfer from one firm 
to another
The ability of transferring tacit knowledge is positively 
related to collaboration with professional research 
Organizations.56,65
Ability firm The ability of a firm to appropriate research 
findings
The success rate of an R&D collaboration is positively 
related to the ability of a firm to appropriate research 
findings.56,61,65
in relationships) and performance risk (trust in a positive 
outcome of the collaboration).
Based on the stated necessary resources in an alliance 
and the two types of risks, a framework was developed (see 
Table 2) to understand the prime objectives of a partner in the 
process of forming their R&D collaborations.57 For example, 
when a firm (box 2 in Table 2) contributes financial resources 
and expects high project performance risks, that is low success 
rates, it is more likely that it will join the collaboration when 
the anticipated profits are high, and there are exit provisions 
in the contract. In contrast, for example, when a firm (box 3 
in Table 2) contributes technological knowhow to the project, 
and expects high relational risks, such as unwanted spill-overs, 
it is more likely that it will join the collaboration when it can 
safeguard its knowledge by patenting.
An R&D collaboration can be divided into two types of 
collaboration, namely horizontal and vertical. A vertical R&D 
collaboration is essentially a collaboration between a supplier 
and a client. A horizontal collaboration is a collaboration 
between two competitors.
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Next, we move from listing the relevant determinants 
to formulating the guidelines, which are themselves 
recommendations, not rules, based on how these relevant 
determinants affect the success rate of an R&D collaboration 
project. From Table 1, the descriptions of the influences of 
the determinants can be used as a guideline in the process 
of forming an R&D collaboration between two partners. 
For example, it has been concluded that the size of a firm, 
and its prior experience with R&D collaborations, have a 
positive impact on the propensity of a firm to form R&D 
collaborations. It implies that, when you are in the position to 
choose between two otherwise similar firms, you are advised 
to start the formation process with the larger firm that has 
more experience on collaborations. Table 2 can be used to 
categorize a firm’s prime considerations in the process of 
forming an R&D collaboration.
Among the inter-organizational collaborations that have 
been studied there are many collaborations between two 
partners, but can we also apply the above findings fully 
to a multi-partner collaboration, important for biobased 
innovations? We will address this question in the next section.
Multi-partner R&D collaboration
This section addresses the relevant literature on multi-partner 
R&D collaborations. It is divided into four subsections: 
determinants of a multi-partner R&D collaboration, conflicts 
in the literature addressing these determinants, complexity of 
projects, and biobased R&D collaborations.
Determinants of a multi-partner R&D 
collaboration
This subsection gives an overview of the determinants of a 
multi-partner R&D collaboration, including publications 
concerning multi-partner alliances and networks. Note that 
we stay away from the literature on the alliance portfolio 
of individual firms66 to focus instead on multi-partner 
R&D collaborations. A multi-partner alliance brings 
additional complexity, on the one hand, going beyond 
the mere summation of the collaborations between two 
partners.67 On the other hand, such alliances focus attention 
more narrowly, thus only on a subset of all the ties that 
comprise an innovation network.18 An innovation network 
can be defined as a loosely tied group of organizations 
that may consist of members from industry, government, 
and research institutes collaborating to achieve common 
innovation goals.68 The formation processes of multi-
partner R&D collaborations can be enriched by studying 
the collaborations as an innovation network forms.69 We 
divided the determinants for the formation process of 
a multi-partner R&D collaboration into the same three 
groups as in the previous section: partner properties, 
motives, and appropriability. Project properties are 
added as a fourth group, which the literature describes 
as determinants for a multi-partner R&D collaboration. 
In Table 3 we give a description of all the determinants 
mentioned above and their influences on the process of 
forming a multi-partner R&D collaboration.
In general, the literature is clear on individual determinants, 
and the influence on the process of forming collaborations is 
straightforward. The studies regarding R&D intensity, prior 
experience, and the degree of industry competition give 
conflicting results (Table 3).
Conflicts in the literature addressing 
determinants
This subsection addresses the three conflicting results in 
literature regarding determinants for the formation process of 
a multi-partner collaboration and their influences. According 
to a Japanese case study, the R&D intensity of the firms in the 
consortium is positively related to the process of forming an 
R&D consortium.70 This is comparable to the results regarding 
collaborations between two partners (Table 1). However 
a Taiwanese case study concluded that R&D intensity has 
no significant influence on the behavior of firms joining 
a multi-partner R&D collaboration.71 Another case study 
also focused on the determinants influencing the creation 
of new resources.72 The results of the latter study show that 
firms with strong internal capabilities (R&D intensity) and 
linkage of their assets and goals to the collaboration develop 
resources (e.g. products, patents, prototypes, competences).72 
Based on the foregoing literature, we derive that the effect 
of the R&D intensity of a firm on an R&D collaboration can 
Table 2. Strategic alliance making orientations.57
Alliance 
resources
High relational risk High performance 
risk
Financial Box 1
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Table 3. Determinants for the formation process of a multi-partner collaboration and their influences.
Determinant Description Description of influence Contrasting results
Partner properties
Size The number of employees 
within a firm
Positively related to the formation of an 
R&D consortium70
Firm age The number of years the firm 
exists
Positively related to the formation of an 
R&D consortium70,71
R&D intensity The annual R&D investments 
divided by the sales of that 
year
Positively related to the formation of an 
R&D consortium71
No significant influence on 
formation70
Prior experience The amount of experience of a 
firm with R&D collaborations
Positively related to the formation of an 
R&D consortium71
No significant influence70,73,74
Prior experience The partners know each other 
from previous projects




The ability of a firm to build 
networks
Positively related to the formation of an 
R&D consortium71,73
Type of partner Horizontal versus vertical 
collaboration
An horizontal R&D consortium is hard 
to establish. Severe circumstances 
are necessary for competitors working 
together.14
R&D consortia consisting of both 
horizontal and vertical collaboration 
(horizontal-vertical collaboration) appear 
to be stronger than pure horizontal or pure 
vertical collaborations14
Type of partner The degree of industry 
competition a firm is part of
The higher this degree the more there is a 
tendency to join an R&D consortium.70
Contrary results71
Type of partner The degree of product market 
competition among consortium 
members
The degree is negatively associated with 
the outcome of an R&D consortium64,77
Type of partner Type of industry: for example 
chemical, food, energy
A diverse portfolio is positively related to 
the formation of an R&D consortium70,71
Type of partner Type of industry: for example 
chemical, food, energy
A diverse portfolio in partners is better 
for the performance of a collaboration. 




The geographic distance 
between the two partners
Negatively related to the formation of an 
R&D consortium74,79
The formation of high-tech 
industrial clusters on a location 
can nullify the advantage of a local 
partner because of the lack of 
privacy80
Motives
Motives The motive of a firm to join an 
R&D collaboration




condition of a  
firm
The number of patents filed by 
the firm
Positively related to the rate of R&D 
consortia formation70,71
Spillover The knowledge obtained by a 
partner from the other partner 
during the project
Positive influence on the outcome of an 
R&D consortium77
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Determinant Description Description of influence Contrasting results
Project properties
Type of R&D Type of project: Basic 
research, applied research, 
and development
Collaborations have more impact when 
they conduct relatively basic, rather than 
relatively applied R&D64,77
Type of project Exploitation versus exploration 
project
The factors, size of the consortium, type 
of partner, density and intensity of the 
network, are different for exploitation 
projects than for exploration projects81
Table 3. (Continued).
vary depending on the phase of the collaboration. The R&D 
intensity had little effect on the formation process71 but has 
serious effects on the resources created.72
The Japanese case study mentioned above also showed 
a positive relationship between prior experience and the 
formation process of an R&D consortium. However, other 
more recent studies could not find a significant influence 
of prior experience on the formation process of an R&D 
collaboration.71,73,74
Finally, regarding industry competition, we find that an 
R&D consortium with competing partners (horizontal 
consortium) is hard to establish. Difficult circumstances are 
needed for competitors to work together14 – for example, 
when he development of a next-generation product is far 
too risky and too expensive for a single firm to carry on its 
own. The higher the degree of industry competition, the 
more there is a tendency to join an R&D consortium.71,75 
The differences in the findings of similar studies have been 
explained by differences in actions between well-established 
firms and emerging firms.70 In the earlier Japanese case 
study70 only a minority of the partners were emerging firms. 
In contrast, from a study on firms that catch up on emerging 
technologies it is clear that, in that case, a collaboration 
between emerging competitors is really necessary.71
Complexity of projects
In this section we look at complexity of a foreseen multi-
party project in relation to the conflicts in results described 
in the previous section. How can we explain these conflicts? 
The complexity of an R&D project depends on several 
determinants, such as the type of partners, type of project, 
type of consortium and type of innovation. Table 4 specifies 
these determinants and their influence on the formation 
process of multi-partner R&D collaborations.
The information in Table 4 can be used as a guideline, 
consisting of recommendations rather than rules, for the 
process of forming an R&D collaboration. For example, if 
one wants to set up a consortium to develop an incremental 
innovation, that consortium preferably consists of firms 
involved across stages of the value chain. However, it 
becomes a different situation where both options of one 
determinant are applicable. For example, when the project 
involves both exploration and exploitation, it is not clear 
which study result is applicable: The influences of the factors 
size of the consortium, type of partner, density and intensity 
of the network, are different for exploitation projects 
and exploration projects. The more both options of the 
determinants of an R&D collaboration are applicable, the 
higher the degree of complexity of an R&D collaboration, 
and the less applicable is the information in Table 4 as a 
guideline during the process of forming a multi-partner 
collaboration. This can also be the reason for the conflicting 
results in Table 2. Further research is necessary on this 
matter.
Biobased multi-partner R&D 
collaborations
In addition to the complexities of a multi-partner 
collaboration, biobased collaborations may have 
characteristics, described above, that make a collaboration 
more complex. The influence of the type of innovation 
(drop-ins versus novel materials), biorefinery, biomass 
supply, and technological challenges to the collaboration 
have not been studied as yet. Variables regarding new 
collaborations (like strong and weak ties) and new chains 
(like network wholes) have been addressed in network 
theory studies,76,81,82 but the effects of these variables on a 
biobased R&D collaboration have not been studied. This 
leads to the following overall conclusion: the complexity of 
biobased R&D collaborations can differ. So if we apply the 
above presumption to biobased R&D collaborations, the 
information in Tables 2 and 4 can be used as a guideline for 
relatively less complex collaborations. It does not, however, 
apply straightforwardly to complex collaborations. These 
collaborations may require an orchestrator as a triggering 
entity. Further research into these issues is needed.
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Table 4. Determinants influencing the complexity of an R&D collaboration.
Determinants and options Description of the influence
Type of partners
Well-established versus emerging technologies Catching up on emerging technologies: a collaboration between 
competitors is necessary.
Well-established technologies: No influence of the type of partners.70,71
Partners with state-of-the-art technology versus others A partner with state-of-art technology tends to join an R&D collaboration 
because by joining the collaboration it can decrease the R&D 
expenditure and increase the R&D capacity. A partner with outdated or 
no technology needs to scale up its own R&D activities.12
Type of project
Exploitation versus exploration The influences of the determinants, size of the consortium, type of 
partner, density and intensity of the network, are different for exploitation 
projects vs exploration projects.81
Type of consortium
Horizontal versus vertical R&D consortia consisting of both horizontal and vertical collaborations 
(horizontal-vertical collaboration) appear to be stronger than purely 
horizontal or purely vertical collaborations.14
Type of innovation
Incremental versus radical A radical innovation has a higher chance to succeed in a horizontal 
consortium or if the partners come from a different kind of industry. An 
incremental innovation has a higher chance to succeed in a vertical 
consortium and / or more geographically distributed partners.14,52,82–84
Orchestration of the formation 
process
The process of forming an R&D consortium and the 
corresponding decisions can be orchestrated by a 
triggering entity. Doz and Baburoglu47 describe two 
types of formation processes: emergent and engineered 
processes. In an emergent process a collaboration is driven 
by interdependencies (e.g. common threats, finding access 
to similar resources) and similar interests of the partners. 
An engineered process is led by a triggering entity. This 
entity may have great added value for the formation process 
by taking the lead in three main functions: innovation 
initiation, network composition, and innovation process 
management.16 This orchestrator therefore affects the 
type of partners (size, diversity), network structure (density, 
autonomy) and network position (centrality, status).17
Table 5 gives an overview of the characteristics of emergent 
and engineered formation processes and the differences 
between the two. These characteristics can be used to 
categorize the formation process of a collaboration to better 
understand the process itself and the orientation of the final 
consortium. Consortia formed through engineered processes 
may be more likely to have an explorative orientation. 
On the other hand, the orientation of consortia formed 
through emergent processes is more likely to be focused 
on exploitation.18 Although engineered collaborations are 
not likely to involve competitors, a neutral party like an 
orchestrator can help to account for competitors being able to 
collaborate on a specific project while remaining competitors 
elsewhere.12
Over time, one type of formation process can transform 
into the other type.18 For instance, as the partners in a 
collaboration created by an engineered process improve 
their relationship and see that they have similar interests, 
then the context may be created for an emergent process to 
develop. For the survival of an R&D collaboration over time 
it is important to realize a balance between efficiency and 
innovation, and therefore a balance between characteristics 
from both emergent and engineered processes.12,18
Based on the two types of processes (engineered and 
emergent) and the motivation to join an R&D consortium 
(network cooperation or risk sharing), four types of partners 
(see Table 6) can be described with appropriate success 
rates: community builders, gamblers, visible hands, and 
opportunists.15
The information in Tables 5 and 6 can be used ex ante to 
better understand the formation process of a multi-partner 
R&D collaboration by categorizing the formation process 
(emergent or engineered) and the motives of the partners 
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Table 5. Differences between emergent and engineered processes.18
Activity Emergent process Engineered process
Characterization of network Competitive collaboration Options exploration
Environmental interdependencies Strong effect Less pronounced effect
Similar interest Strong effect Less pronounced effect
Triggering entity No direct effect may not be required Necessary for formation process
Open solicitation Open to interested parties, likely to be 
similar organization – snowball effect
Triggering entity targets diverse members – 
hub and spoke effect
Seeking domain consensus Defining boundaries Aligning interests
Expectations of continuity Strong, until opportunity or threat is dealt 
with
Very low at onset
Formal structure Tight coupling to constrain opportunism Filling structural holes, loose coupling
Escalation of commitment and satisfaction Tight of escalation and disappointment Unmet expectations unless transformed
Evidence of learning Contingent on nature of the context Likely to be low
Table 6. Types of partners in an R&D consortium.15
Motive
Process Network cooperation Risk sharing
Emergent Community builders Gamblers
No dominant player and no one player can do it alone Fears over appropriability of R&D need to be balanced 
over the lack of resources
Engineered Visible hands Opportunists
Concerns for legitimacy outweigh lack of technological 
democracy
Pay or bribe firms to share vision or have firms pay to 
explore that vision
(network cooperation or risk sharing). Again, if the formation 
process becomes more complex, showing characteristics of 
both an engineered process (orchestrator) and an emergent 
process (environmental interdependencies), Table 5 is less 
useful for the process of forming a multi-partner R&D 
collaboration. Moreover, if the partners of the collaboration 
have different motives (e.g. network cooperation, risk 
sharing), the typification of partners (Table 6) is also less 
useful for the process of forming a multi-partner R&D 
collaboration. Thus, the conclusions in the previous section 
regarding the complexity of a biobased R&D collaboration 
also apply to the orchestration of the formation process.
Conclusions
This paper provided an overview of the relevant transition 
and innovation models that can be used to analyze and 
improve the process of forming an R&D collaboration. 
Transition models can give a broader perspective on an 
innovation and the variables involved. In addition to the 
type and sequence of steps of an innovation, a transition 
model analyzes the world around it at landscape and 
regime level. An SNM/MLP analysis gives a description 
of the niche, regime, and landscape level relevant for a 
specific innovation and the variables involved. For example, 
information about the stakeholders at the regime level is 
useful for the partner search during the formation process. 
For instance, in situations of globally expected rising oil 
prices, chemical companies without ownership of a naphtha 
cracker for the production of their feedstock from oil may be 
more willing to look for feedstock diversification and thus 
consider biomass as a raw material. These companies are 
potential partners for biobased developments. Changes in 
the landscape and regime level can thus create opportunities 
and threats for the innovation. A TIS analysis can be used 
to analyze the status of the R&D consortium during the 
formation process at a certain moment in time based on 
seven functions (entrepreneurial activities, knowledge 
development, knowledge exchange, guidance of the 
search, formation of markets, mobilization of resources, 
and counteracting resistance to change) and point out the 
possible underdeveloped functions. Innovation models give 
a useful insight into the type and sequence of the steps of an 
innovation – the steps that one needs to take before market 
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Table 7. Variables for the formation process of a biobased R&D collaboration.
Category Variables
Social/consortium
Biobased characteristics: Type of innovation, new collaborations, technological challenges, new chains/
market players and societal sensitive issues
Partner properties, motives, appropriability and type of partner (Tables 1–4)
Project properties: Type of R&D, type of project, resources and risks) (Tables 2–4)
Type of consortium: horizontal versus vertical (Table 4)
Technological
Biobased characteristics: Type of innovation, bio-refinery, biomass supply, technological challenges
Project properties: type of R&D (Table 3)
Type of innovation: incremental versus radical (Table 4)
Economic
Biobased characteristics: Type of innovation, bio-refinery, new collaborations, biomass supply, 
technological challenges, new chains and market players
Partner properties, motives, appropriability and type of partner (Tables 1–4)
Project properties: Type of R&D, type of project, resources and risks) Tables 2-4
Type of consortium: Horizontal versus vertical (Table 4)
Type of innovation: Incremental versus radical (Table 4)
Environmental/biobased
Environmental characteristics: CO2 reduction, renewable resources
Biobased characteristics: Type of innovation e.g. environment friendlier alternatives
introduction. Based on these steps, choices have to be made 
by firms / brokers during the process of forming a biobased 
R&D consortium. We conclude that, although each model 
has its advantages, as far as we know, none of the transition 
and innovation models in literature addresses both the 
formation process phases of a biobased R&D collaboration 
and the variables involved.
A vast amount of research has been done on the general 
determinants of an R&D collaboration. Partner properties, 
motives to join a consortium, and appropriability of a firm are 
the main determinants of an R&D collaboration between two 
partners. The literature describes another group determinant 
for a multi-partner R&D collaboration: project properties. The 
influence of biobased characteristics such as type of innovation 
(drop-ins versus novel materials), biorefinery, biomass supply, 
and technological challenges on the formation process of an 
R&D collaboration is not addressed in the literature.
Table 7 gives an overview of the variables (biobased 
characteristics and general determinants) addressed in 
the literature regarding biobased R&D collaborations 
based on the well-known Social, Technological, Economic, 
Environmental, Political variables (STEEP) categorization. 
The literature has given little attention to the effect of 
political variables on the process of forming an R&D 
collaboration. The effect of legal variables like subsidies and 
contracts on the other hand has been studied extensively. 
This is a major topic on its own and therefore we did not 
address it in this paper.
These variables from a wide range of categories affect 
a biobased R&D collaboration. A model describing the 
process of forming a biobased R&D collaboration should 
therefore address these variables. Such a model is not yet 
available in the literature. The description of the influences 
of the variables in Tables 1, 3, and 4 can be used as a 
guideline, as recommendations, and the information in 
Tables 2, 5 and 6 can be used to better understand the 
formation process of an R&D collaboration. However, we 
also recognize that the more complex an R&D collaboration, 
the more the influences of the determinants of the R&D 
collaboration may counteract each other, and the less clear-
cut the information is for the process of forming the R&D 
collaboration.
Doz and Baburoglu47 describe two types of formation 
processes: emergent and engineered processes. An 
engineered process is led by an orchestrator. An 
orchestrator may have great added value for the process 
of forming an R&D collaboration by taking the lead in 
three main functions: innovation initiation, network 
composition, and innovation process management. 
Especially for biobased R&D collaborations, where 
partners from different sectors often need to collaborate, an 
orchestrator can play a vital role.
Further dedicated research into complex multi-partner 
R&D collaborations in specific biobased collaborations 
and their determinants is essential, to better understand 
the formation processes of these R&D collaborations. 
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Furthermore, the formation process influences the success 
of a multi-partner R&D collaboration, but, as far as we 
know, there is no model in the literature addressing the 
relevant variables (e.g. economic, social, and technological) 
per phase, to analyze and improve this formation process. 
Finally, further research is needed to determine the influence 
of biobased characteristics on the process of forming a 
multi-partner R&D consortium. We want to pursue this 
research agenda and invite others to join in, to the benefit of 
a successful transition to the biobased economy.
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